FDA NEW GUIDANCE


FDA has issued a draft guidance intended to help sponsors develop antidiabetic drugs for adults and children with type 1 diabetes mellitus (T1D) and/or type 2 diabetes 

 https://www.linkedin.com/posts/fda_guidance-document-for-industry-activity-7067597765677064192-PkJO?utm_source=share&utm_medium=member_ios

Comments

Popular posts from this blog

BROWN SPOTS, what are the solutions to mitigate them?

Stress Management: An Overview of Strategies and Techniques

Pharmacovigilance